Teva Pharmaceuticals on X: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Teva CEO sees no value now in separating brands, generics businesses | Seeking Alpha
Teva Pharmaceuticals on X: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva CEO on Advancing Health Care | BCG
Teva CEO exits amid crisis of confidence at drugmaker
Months after joining, Teva CEO pulls curtain back on strategy to return to growth
Teva CEO: Israel's production capacity has not been affected by the war | Ctech
Erez Vigodman steps down as Teva CEO
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO Richard Francis on Q2 earnings beat
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Mary Doyle - Sr. Executive Assistant Global Marketing & Portfolio & Specialty Marketing North America - Teva Pharmaceuticals | LinkedIn
Teva Names Erez Vigodman as President and CEO | Business Wire
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
